ABOUT THIS EPISODE
Dexcom has heard the community's concerns around sensor accuracy, connectivity, adhesive performance, and transparency. In this episode, I sit down with Dexcom CEO Jacob Leach and CTO Peter Simpson to discuss how the company is addressing those concerns, improving the Dexcom G7, and working to rebuild trust with users. We also get an exclusive look at the future of Dexcom, including enhanced algorithms, improved reliability, the upcoming Dexcom G8, and advancements in continuous glucose monitoring like multi-analyte sensing and potassium tracking.
Learn about Omnipod 5 (today's sponsor)*
Learn about the Eversense 365 CGM
T1D Exchange Registry Sign up (US residents only)
Join: Diabetech Newsletter (free) | Diabetech All Access
Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord
DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.
*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
